Lakefront Biotherapeutics NV (LKFT) stock
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)
Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –
Lakefront Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lakefront Biotherapeutics's market cap was $2.20B on Nov 11, 2026, against $2.06B a year earlier. Over the last 5 years it ranged from $1.52B to $4.39B, with a median of $2.20B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.20B | +2.0% |
| 2025 | Dec 31, 2025 | $2.15B | +18.9% |
| 2024 | Dec 31, 2024 | $1.81B | -32.2% |
| 2023 | Dec 29, 2023 | $2.67B | -8.1% |
| 2022 | Dec 30, 2022 | $2.91B | -19.0% |
| 2021 | Dec 31, 2021 | $3.59B | -37.1% |
| 2020 | Dec 31, 2020 | $5.70B | -47.1% |
| 2019 | Dec 31, 2019 | $10.78B | +137.5% |
| 2018 | Dec 31, 2018 | $4.54B | +2.3% |
| 2017 | Dec 29, 2017 | $4.44B | +93.6% |
| 2016 | Dec 30, 2016 | $2.29B | – |
See a number that looks wrong?